The Journal of Practical Medicine >

2025 , Vol. 41 >Issue 3: 313 - 321

DOI: https://doi.org/10.3969/j.issn.1006-5725.2025.03.002

Basic Research

Role of Toll⁃like receptor 4 in regulation of homocysteine⁃induced ferroptosis in macrophages

  • Junjie ZHAI ,
  • Shaoying WEN ,
  • Xinru LI ,
  • Rui SUN ,
  • Ning QI ,
  • Qifan ZHANG ,
  • Li YANG ,
  • Hui HUANG ,
  • Lingju MA ,
  • Yinju HAO ,
  • Yideng JIANG ,
  • Guizhong LI ,
  • Shengchao. MA
Expand
  • *.Key Laboratory of Metabolic Cardiovascular Disease Research of National Health Commission，Yinchuan 750004，Ningxia，China

Received date: 2024-08-16

  Online published: 2025-02-19

Fold

Abstract

Objective To investigate the role of Toll-like receptor 4 （TLR4） in the regulation of homocysteine （Hcy）-induced ferroptosis in macrophages. Methods Mouse macrophage cells RAW264.7 were cultured and divided into control group， Hcy intervention group （Hcy group）， and Hcy plus ferroptosis inhibitor group （Hcy+Fer-1 group）. After transfection with interference fragments， macrophages were treated with Hcy， and then divided into control group， Hcy intervention group （Hcy group）， TLR4 interference negative control plus Hcy intervention group （si-NC+Hcy group）， and TLR4 interference plus Hcy intervention group （si-TLR4+Hcy group）. Macrophages were transfected with overexpression lentivirus and treated with Hcy， then were divided into control group， Hcy intervention group （Hcy group）， a TLR4 overexpression negative control plus Hcy intervention group （OE-NC+Hcy group）， and a TLR4 overexpression plus Hcy intervention group （OE-TLR4+Hcy group）. After 48 hours of intervention， real-time fluorescent quantitative PCR and western blot were used to detect the expression levels of TLR4 in macrophages treated with Hcy； western blot was used to detect the expression levels of ferroptosis-related proteins ACSL4， GPX4， and FTH1 in macrophages， and ferrous ion assay kit to detect the concentration of Fe2+ in macrophages； reactive oxygen species （ROS） assay kit and laser confocal microscopy were used to detect the content of intracellular reactive oxygen species. Results Compared with those in the control group， the expression level of the pro-ferroptosis protein ACSL4 was increased in the Hcy group （P < 0.05）， while the expression levels of anti-ferroptosis proteins GPX4 and FTH1 were decreased （P < 0.05）； the concentration of Fe2+ was increased （P < 0.05）， and the content of ROS was increased. Meanwhile， the protein and mRNA expression levels of TLR4 were both increased in the Hcy group （P < 0.05）. After macrophages were transfected with TLR4 interference fragments， compared with those in the si-NC+Hcy group， the expression levels of GPX4 and FTH1 were increased （P < 0.05）； the expression level of ACSL4 was decreased （P < 0.05）； the concentration of Fe2+ was decreased （P < 0.05）， and the content of ROS was reduced in the si-TLR4+Hcy group. After macrophages were transfected with TLR4 overexpression lentivirus， compared with those in the OE-NC+Hcy group， the expression levels of GPX4 and FTH1 were decreased （P < 0.05）， and the expression level of ACSL4 was increased （P < 0.05） in the OE-TLR4+Hcy group. Conclusion Hcy induces the occurrence of ferroptosis in macrophages， and Toll-like receptor 4 has a positive feedback regulatory effect on ferroptosis in macrophages.

Key words： TLR4; macrophages; homocysteine; ferroptosis

Cite this article

Junjie ZHAI , Shaoying WEN , Xinru LI , Rui SUN , Ning QI , Qifan ZHANG , Li YANG , Hui HUANG , Lingju MA , Yinju HAO , Yideng JIANG , Guizhong LI , Shengchao. MA . Role of Toll⁃like receptor 4 in regulation of homocysteine⁃induced ferroptosis in macrophages[J]. The Journal of Practical Medicine, 2025 , 41(3) : 313 -321 . DOI: 10.3969/j.issn.1006-5725.2025.03.002

References

1 JOSEPH P， YUSUF S. Coordinating Efforts to Reduce the Global Incidence of Cardiovascular Disease［J］. N Engl J Med， 2023， 389（14）：1329-1331. doi:10.1056/nejme2309401
2 中国心血管健康与疾病报告编写组. 中国心血管健康与疾病报告2022概要［J］.中国循环杂志， 2023，38（6）：583-586. doi:10.3969/j.issn.1000-3614.2023.06.001
3 方霆锋，江敏，胡炎伟.动脉粥样硬化斑块组织驻留巨噬细胞的研究进展［J］.中国心血管杂志， 2024， 29（3）：283-288.
4 程陈， 张静， 黄萃园， 等. 胞葬作用缺陷在动脉粥样硬化发病机制中的研究进展［J］.中国循环杂志， 2024， 39（4）： 410-416.
5 CHEN W， SCHILPEROORT M， CAO Y， et al. Macrophage-targeted nanomedicine for the diagnosis and treatment of atherosclerosis［J］. Nat Rev Cardiol， 2022， 19（4）：228-249. doi:10.1038/s41569-021-00629-x
6 BALINT B， JEPCHUMBA V K， GUéANT J L， et al. Mechanisms of homocysteine-induced damage to the endothelial， medial and adventitial layers of the arterial wall［J］. Biochimie， 2020， 173：100-106. doi:10.1016/j.biochi.2020.02.012
7 KUMAR A， PATHAK R， PALFREY H A， et al. High levels of dietary methionine improves sitagliptin-induced hepatotoxicity by attenuating oxidative stress in hypercholesterolemic rats［J］. Nutr Metab （Lond）， 2020， 17：2. doi:10.1186/s12986-019-0422-z
8 PETER K， ZUZANA T， KMETOVA M S， et al. Homocysteine and mitochondria in cardiovascular and cerebrovascular systems［J］. Int J Mol Sci， 2020， 21（20）：7698-7698. doi:10.3390/ijms21207698
9 RONALD J A， CHEN J W， CHEN Y， et al. Enzyme-sensitive magnetic resonance imaging targeting myeloperoxidase identifies active inflammation in experimental rabbit atherosclerotic plaques［J］. Circulation， 2009， 120（7）：592-599. doi:10.1161/circulationaha.108.813998
10 ROSHAN M H， TAMBO A， PACE N P. The Role of TLR2， TLR4， and TLR9 in the Pathogenesis of Atherosclerosis［J］. Int J Inflam， 2016， 2016：1532832. doi:10.1155/2016/1532832
11 JEBARI-BENSLAIMAN S， GALICIA-GARCíA U， LARREA-SEBAL A， et al. Pathophysiology of Atherosclerosis［J］. Int J Mol Sci， 2022， 23（6）：3346. doi:10.3390/ijms23063346
12 KUZNETSOVA T， PRANGE K H M， GLASS C K， et al. Transcriptional and epigenetic regulation of macrophages in atherosclerosis［J］. Nat Rev Cardiol， 2020， 17（4）：216-228. doi:10.1038/s41569-019-0265-3
13 DE MEYER G R Y， ZUREK M， PUYLAERT P， et al. Programmed death of macrophages in atherosclerosis： Mechanisms and therapeutic targets［J］. Nat Rev Cardiol， 2024， 21（5）：312-325. doi:10.1038/s41569-023-00957-0
14 CALDERóN-LARRA?AGA A， SAADEH M， HOOSHMAND B， et al. Association of Homocysteine， Methionine， and MTHFR 677C>T Polymorphism With Rate of Cardiovascular Multimorbidity Development in Older Adults in Sweden［J］. JAMA Netw Open， 2020， 3（5）：e205316. doi:10.1001/jamanetworkopen.2020.5316
15 HU G， YUAN Z， WANG J. Autophagy inhibition and ferroptosis activation during atherosclerosis： Hypoxia-inducible factor 1α inhibitor PX-478 alleviates atherosclerosis by inducing autophagy and suppressing ferroptosis in macrophages［J］. Biomed Pharmacother， 2023， 161：114333. doi:10.1016/j.biopha.2023.114333
16 LI N， JIANG W， WANG W， et al. Ferroptosis and its emerging roles in cardiovascular diseases［J］. Pharmacol Res， 2021， 166：105466. doi:10.1016/j.phrs.2021.105466
17 SUN Y， CHEN P， ZHAI B， et al. The emerging role of ferroptosis in inflammation［J］. Biomed Pharmacother， 2020， 127：110108. doi:10.1016/j.biopha.2020.110108
18 王晓燕， 邹小义， 祝翔， 等. 铁超载调控氧化性低密度脂蛋白诱导泡沫细胞促动脉粥样硬化活化的作用［J］. 实用医学杂志， 2024， 40（3）：295-301. doi:10.3969/j.issn.1006-5725.2024.03.003
19 BAI T， LI M， LIU Y， et al. Inhibition of ferroptosis alleviates atherosclerosis through attenuating lipid peroxidation and endothelial dysfunction in mouse aortic endothelial cell［J］. Free Radic Biol Med， 2020， 160：92-102. doi:10.1016/j.freeradbiomed.2020.07.026
20 刘洋， 孙岳， 杨安宁， 等. 铁死亡参与高脂饮食诱导的ApoE（-/-）小鼠动脉粥样硬化及ox-LDL诱导的泡沫细胞形成过程［J］. 实用医学杂志， 2021， 37（5）：585-590.
21 MARTINET W， COORNAERT I， PUYLAERT P， et al. Macrophage Death as a Pharmacological Target in Atherosclerosis［J］. Front Pharmacol， 2019， 10：306. doi:10.3389/fphar.2019.00306
22 GAO D， HU L， LV H， et al. Ferroptosis Involved in Cardiovascular Diseases： Mechanism Exploration of Ferroptosis' Role in Common Pathological Changes［J］. J Cardiovasc Pharmacol， 2024， 83（1）：33-42. doi:10.1097/fjc.0000000000001507
23 WU M， HUANG Z， ZENG L， et al. Programmed Cell Death of Endothelial Cells in Myocardial Infarction and Its Potential Therapeutic Strategy［J］. Cardiol Res Pract， 2022， 2022：6558060. doi:10.1155/2022/6558060
24 WANG W， LIU W， FIDLER T， et al. Macrophage Inflammation， Erythrophagocytosis， and Accelerated Atherosclerosis in Jak2 V617F Mice［J］. Circ Res， 2018， 123（11）：e35-e47. doi:10.1161/circresaha.118.313283
25 WEI J， ZHANG Y， LI H， et al. Toll-like receptor 4： A potential therapeutic target for multiple human diseases［J］. Biomed Pharmacother， 2023， 166：115338. doi:10.1016/j.biopha.2023.115338
26 BAGHERI B， KHATIBIYAN FEYZABADI Z， NOURI A， et al. Atherosclerosis and Toll-Like Receptor4 （TLR4）， Lectin-Like Oxidized Low-Density Lipoprotein-1 （LOX-1）， and Proprotein Convertase Subtilisin/Kexin Type9 （PCSK9）［J］. Mediators Inflamm， 2024， 2024：5830491. doi:10.1155/2024/5830491
27 DUFRUSINE B， FRANCESCO D A， ODDI S， et al. Iron-Dependent Trafficking of 5-Lipoxygenase and Impact on Human Macrophage Activation［J］.Front Immunol， 2019， 10：1347. doi:10.3389/fimmu.2019.01347
Options
Outlines

/

〈 〉